SCHEMBL4808347

SCHEMBL4808347

C[C@H](N)Cn1ncc2ccc(C(N)=O)cc21

nearest known ligand 0.67

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 16/20 0.67
HTR2C P28335 16/20 0.67
HTR2B P41595 7/20 0.67
HTR1A P08908 2/20 0.67
ADRA2A P08913 2/20 0.67
ADRA2B P18089 2/20 0.67
ADRA2C P18825 2/20 0.67
HTR1D P28221 1/20 0.67
HTR7 P34969 1/20 0.67
HTR4 Q13639 1/20 0.67
KMO O15229 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4808355 1.00 HTR2A (0.67) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL4198159 0.90 HTR2A (0.53) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL4804854 0.84 HTR2A (0.60) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL4804848 0.84 HTR2A (0.60) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL29426218 0.83 PTGER3 (0.51) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL6088764 0.80 HTR2A (1.00) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL31079586 0.80 HTR2A (1.00) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL4779282 0.80 HTR2A (1.00) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL475894 0.80 HTR2A (1.00) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL4857914 0.79 HTR2A (0.64) HTR2AHTR2CHTR2BKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439262-B1 Substituted 1-alkylamino-1-H-indazoles for the treatment of glaucoma ALCON, INC. (CH) 2008-10-21 US disclosed
US-7338972-B1 Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma ALCON, INC. (CH) 2008-03-04 US disclosed